TechniScan Medical receives second-phase SBIR funding

TechniScan Medical Systems Inc., a Salt Lake-based developer of ultrasound technology for breast imaging, said Tuesday it has received a continuation of its Small Business Innovation Research funding from the National Cancer Institute.

The $1.66 million in Phase II money will be for a 12-month period.

The company previously received $200,000 in Phase I development funds. It will receive about $1 million in Phase III next year.

Phase I funds were used to design technical improvements to the company's prototype imaging system, which was completed earlier this year. The Phase II funds will be used for production of two systems modeled on the improved prototype. Phase III work involves investigational testing of patients at the the University of California San Diego and at the Mayo Clinic in Rochester, Minn.